PanTheryx Stock
Intestinal health research, development, and commercialization products
About PanTheryx Stock
PanTheryx is a U.S. medical nutrition company focused on the research, development, and commercialization of products that promote intestinal health. The company is engaged in the discovery and development of its proprietary technology platform, advancing clinical testing, and the commercialization of its products that both address the specific dietary needs of children with infectious diarrhea, and support overall intestinal health. The company’s medical nutrition products are regulated in three FDA categories: medical foods, food for special dietary use, and dietary supplements. PanTheryx was founded in 2007 by Mark A. Braman and is based in Boulder, Colorado.
Investors
Funding History
| March 2011 | $1.0M |
|---|---|
| December 2011 | $1.6M |
| August 2012 | $3.5M |
| April 2015 | $9.3M |
| March 2016 | $53.0M |
| September 2017 | $8.9M |
Management
CEO & President
Mark A. Braman
Vice President, Corporate Development and General Counsel
Scott Hyman
Executive Vice President
George Stagnitti
Press
Herald Analyst - Dec, 15 2017
DailyCommerceNews - Dec, 13 2017
Exclusive Herald - Dec, 13 2017
Newsient (blog) - Dec, 1 2017
Drug Store News - Jul, 21 2017
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from PanTheryx or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
